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A B S T R A C T
In this study, the ﬁnished complete genome of Mycobacterium avium subsp. para-
tuberculosis (Map) was screened for speciﬁc coding sequences that could be very valuable
in the design of a sensitive and speciﬁc Map detection serological assay. Eighty-seven
Map-speciﬁc sequences were retained. Among these, three candidate antigens have been
analysed for their serodiagnostic potential. These antigens were selected on the basis of
their putative immunogenicity as predicted by in silico analysis. The antigens were cloned
in Escherichia coli, expressed, and puriﬁed before testing in an antibody detection ELISA
test, using a well characterized panel of 18 and 48 sera from Map infected and uninfected
cattle, respectively. Two of these antigens, antigen 6 and MAP1637c, yielded in our
conditions a sensitivity of 72% and 82%, respectively, for a speciﬁcity of 98%. It is
particularly noticeable that, when probed with the same serum panel, the most widely
used European paratuberculosis commercial seroassay (Pourquier test) yielded a
sensitivity of 72% for a speciﬁcity of only 92%.
 2008 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
Veterinary Microbiology
journa l homepage: www.e lsev ier .com/ locate /vetmic1. Introduction
Bovine paratuberculosis is a chronic granulomatous
enteritis caused by Mycobacterium avium subsp. paratu-
berculosis (Map) and characterised by intermittent diar-
rhoea associated with rapid weight loss. Variable
prevalence has been reported (Cetinkaya et al., 1996;
Giese andAhrens, 2000; Jakobsen et al., 2000; Kennedy and
Benedictus, 2001; Streeter et al., 1995; Wells and Wagner,
2000), ranging between 3.5% and 70% in developed
countries, and annual ﬁnancial losses (Gonda et al.,
2007) were evaluated to $200 million for the US diary
industry alone (Ott et al., 1999).* Corresponding author. Tel.: +32 65373312; fax: +32 65373320.
E-mail address: ruddy.wattiez@umh.ac.be (R. Wattiez).
0378-1135/$ – see front matter  2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetmic.2008.09.065It is largely accepted that major improvements are
needed in currently available serodiagnostic tests to allow
for an efﬁcient control program to be set up (Collins et al.,
2005; Sweeney et al., 2006). Many laboratories have
therefore chosen to improve the efﬁciency of serological
assays by replacing the current common ‘‘extract antigen’’
by ‘‘puriﬁed Map-speciﬁc subunit antigens’’ (Dupont et al.,
2005; Huntley et al., 2005; Olsen et al., 2001; Paustian
et al., 2004; Willemsen et al., 2006). Different approaches
have been used in the search for such antigens. Among
other things we can mention immunoproteomic
approaches, in which antigens are ﬁrstly selected on the
basis of their antigenicity, and genomic approaches, in
which antigens are selected in the ﬁnished genome of Map
on the basis of their sequence speciﬁcity (Li et al., 2005).
Recently, two large-scale immunoproteomic analyses have
been published and reported very promising results
B. Leroy et al. / Veterinary Microbiology 135 (2009) 313–319314obtained via such approach (Cho et al., 2006, 2007; Leroy
et al., 2007). To date, a number of antigens have also been
identiﬁed using the genomic approach, but data about
their reactivity in ELISA using large panels of sera, are still
lacking (Bannantine et al., 2004a, 2004b, 2008a).
Here, we present data on the bioinformatic screening of
the Map genome in search for Map-speciﬁc genes. Among
them, Map-speciﬁc coding sequences predicted to present
the most potent antigenicity, as determined in silico, were
selected for cloning, expression and serological analysis.
Three candidate antigens were selected and probed in an
ELISA test with 66 sera from Map-infected cattle and
negative control cattle. Two of these candidate antigens
were strongly antigenic and might be included in a
diagnostic assay based on puriﬁed antigens.
2. Materials and methods
2.1. Sera
Sera used in this study have already been extensively
described previously (Leroy et al., 2007). Brieﬂy, a panel of
48 sera from two M. bovis infected herds with no known
cases of paratuberculosiswere used as negative controls. All
animals included as negative controls were tested in the in
vitro interferon gamma assay using ESAT6 and CFP10 and
post-mortem by bacterial culture. Most had their M. bovis-
sensitised status conﬁrmed by the interferon gamma test
(41/48), or by post-mortem M. bovis isolation (20/48). 18
sera originating from naturally Map infected cattle were
used to study antigens sensitivity. These animals were 3–5
years old and were either low (5), medium (7) or high (6)
faecal shedders ofMapat timeof sampling. Threehigh faecal
shedders showed clinical signs of JD and 2 out of 4 sacriﬁced
high shedders demonstrated extensive intestinal lesions.
For all 18 positive controls, Map infectionwas conﬁrmed by
faecal culture. Bothpositive andnegative serumpanelswere
testedwith the Pourquier test as reference serological assay.
All data about the sera and results of Pourquier test are
summarised in supplemental Table SI.
2.2. Selection of candidate antigens
Before the availability of the genome ofMap [completed
since February 2004 (Mycobacterium avium subsp.
paratuberculosis str. k10/Li, L., Bannantine, J., Zhang, Q.,
Amonsin, A., Alt, D. and Kapur, V. Direct submission.
Submitted on 5 September 2003 and modiﬁed on 30
January 2004)] it was already feasible to blast against the
available Map contigs on the National Center for Biotech-
nology Information (NCBI) web site (http://www.ncbi.nlm.
nih.gov/BLAST/BLAST.cgi). The genome of Mycobacterium
aviumsubsp.avium (Maa), that is theclosestgenometoMap,
was used as query sequence for a BLASTn against the Map
contigs. As a result all the Map contigs were returned and
assembled in a unique silico-genome of 4,950,895 bases. In
this case, borders of all joined contigs were replaced by N.
Coding sequences (CDS) were detected by the program
GLIMMER. This program tracks down the stop codon of all
genes and predicts a corresponding CDS. GLIMMER was
used because itwas not stopped by the unknown (N) bases.The smallest sequence recognised by GLIMMER is 90 bp
long. Other programs were used to predict the structure
and the localisation of the putative proteins. We used
PsortII for Gram positives, TMHMMand TMPred programs.
A last selectionwascarriedoutusing threedifferentT cell
epitope prediction programs, ‘‘Tsites’’, ‘‘BIMAS’’ and ‘‘SYF-
PEITHI’’, in order to select the most promising antigenic
sequences, with respect to future vaccine development.
2.3. Production of the candidate antigens
Genes encoding candidate antigens were ampliﬁed by
PCR from M. avium subsp. paratuberculosis ATCC 19698
genomic DNA (Rosseels et al., 2006) and initially cloned in
a V1J.ns-tPA vector (Merck Research Laboratories, PA, USA)
(Roupie et al., 2008). Coding sequences were subsequently
subcloned by PCR ampliﬁcation, (Expand High Fidelity PCR
System, Roche) and puriﬁed on agarose gel (QIA quick Gel
extraction kit, Qiagen). The ampliﬁed sequences were
digested with BglII/HindIII (Ag5), with BamHI/HindIII
(Ag6), and with BamHI/PstI (Ag7), puriﬁed on column
(QIAkit PCR kit, Qiagen), and ligated into a pQE-80L
(Qiagen) expression vector predigested with BamHI/
HindIII (Ag5 and Ag6) or with BamHI/PstI (Ag7). After
ligation (T4 DNA ligase, Fermentas) and transformation
into Top-10F’ chemically competent Escherichia coli cells
(Invitrogen) for expression, positive clones were screened
on LB-ampicillin medium (100 mg/ml) and conﬁrmed by
restriction enzyme digestion. The integrity of cloned
sequences was checked by sequence analysis.
For antigenexpression,E. colipositive clonesweregrown
on LB-ampicillinmediumat 37 8C under agitation until they
reached an OD600 nm of 0.6 and antigen expression was
induced by addition of IPTG (1 mM ﬁnal concentration) for
4 h for Ag6, and overnight for Ag5 and Ag7.
Bacteria were lysed using lysozyme (r-lysozyme,
Novagen) and bath sonicator (2  5 min on ice) in
extraction buffer (EB: 50 mM Tris–HCl, pH 7.5, NaCl
500 mM, Imidazole 10 mM, b-MSH 1 mM) containing
8 M urea and protease inhibitors (EDTA free miniprotease
inhibitor tabs, Roche). Extraction efﬁciency of the different
supernatants was analysed by SDS-PAGE.
2.3.1. Puriﬁcation of candidate antigens
His-Select cartridges (Sigma) were used for candidate
antigen puriﬁcation following manufacturer’s instructions.
Candidate antigenswere elutedusing an imidazole gradient
of 10–300mM in 100 ml. To evaluate their homogeneity,
concentrated candidate antigens were analysed in SDS-
PAGE and all Coomassie Brilliant Blue stained bands were
analysed by mass spectrometry. Protein concentrations
were measured using the Non-Interfering Protein Assay kit
(Novagen) following manufacturer’s instructions.
2.4. Protein characterisation by mass spectrometry analysis
The Coomassie stained proteins of interest were cut out,
and destained and washed twice in 25mM NH4HCO3 for
15 min under gentle agitation at room temperature,
followed by two 15-min washes in 25 mM NH4HCO3, 50%
(v/v) CH3CN. Cysteines were carboxyamidomethylated by
B. Leroy et al. / Veterinary Microbiology 135 (2009) 313–319 315incubation of gel pieces in 25mMNH4HCO3, 50 mMDTE for
30 min at 56 8C followed by 30 min in 25mM NH4HCO3,
50 mM iodoacetamide at room temperature in the dark.
After speed vacuum dehydration, 10ml of a 0.02mg/ml
trypsin solution in 25mM NH4HCO3 (Promega, Madison)
was added, and samples were incubated overnight at 37 8C.
Tryptic digestionwas stopped by addition of 1ml of 5% (v/v)
formic acid. For MALDI-TOF analysis, 1ml of each sample
was mixed with 1ml of matrix (5 mg/ml a-cyano-4-
hydroxycinnamic acid and 0.5 pmol/ml rennin as internal
standard, in 25% (v/v) ethanol, 25% (v/v) acetonitrile, 0.05%
(v/v) TFA), then spotted onto a MALDI sample plate and
allowed to air dry. MALDI-TOF was performed using a
M@ldiTM mass spectrometer (Micromass, Manchester, UK)
equippedwith a 337 nmnitrogen laser. The instrumentwas
operated in the positive reﬂectron mode with 15 kV of
source voltage, 2.5 kV of pulse voltage and 2 kV of reﬂecting
voltage. Protein identiﬁcation was realised using Protein-
Lynxglobal server (Micromass) in an in-houseMapgenomic
database, using mass tolerance of 100 ppm, carbamido-
methylation of Cysteine as ﬁxedmodiﬁcation and oxidation
of methionine as variable modiﬁcation.
2.5. Antibody ELISA
The commercial Pourquier ELISAwas performed follow-
ing the manufacturer’s instructions. Candidate antigens
were tested in ELISA on 96 well plates (MaxiSorb, Nunc)
coated overnight at room temperature with 100ml of
candidate antigens diluted at 4mg/ml in 100 mM Na2CO3/
NaHCO3 buffer, pH 9.6, or in formaldehyde 37% (v/v). After
washing three times in PBS containing 0.05% (v/v) Tween 20
(PBST), non-speciﬁc interaction sites were blocked by
incubation with 150ml of 2.5% caseine hydrolysate (w/v)
in PBST. 100ml of sera diluted in PBST containing 1.25%
caseine hydrolysate (w/v) (1:250) were then added and
incubated 1 h at 37 8C. Afterwashing three timeswith PBST,
plates were incubated 1 h at 37 8Cwith 100ml of secondary
antibody diluted in PBST containing 1.25% caseine hydro-
lysate (w/v). Two different HRP conjugated secondary
antibodies were used. The ﬁrst one purchased from
Sigma–Aldrich and raised against bovine Ig was diluted
1:2000. The second one is a monoclonal antibody speciﬁ-
cally directed against type G bovine immunoglobulins. This
antibody developed by Letesson et al. (1985) was kindly
providedbyBio-XDiagnostic (Jemelle, Belgium) anddiluted
1:50. After washing three times with PBST, HRP activity
immobilised on the plate was detected by reaction with
tetramethylbenzidine for 5–15min. Reaction was stopped
by addition of an equal volume of 1N sulphuric acid and
evaluated by colorimetric measurement at 450 nm. ROC
analysis was used to determine best cut-off value and
associated sensitivity and speciﬁcity.
3. Results
3.1. Selection of candidate antigens
7137 CDS were predicted by GLIMMER and submitted
to a BLAST 2.2.3. n (with an e value <10e3) against the
genome of Mycobacterium avium subsp. avium (Maa).After the BLAST, 285 CDS appeared absent from Maa.
Ten sequences were considered as wrong because they
overlapped two contigs. We translated the remaining 275
CDS into protein sequences and used a BLAST 2.2.3. p/nr.:
101 sequences with a hit on proteins from other
mycobacteria were discarded. The ensuing selection of
candidate antigens was based on the analysis of the 174
remaining sequences: ﬁrst, we discarded two sequences
that were overlapping each other, and second the
sequences that were smaller than 120 bp were also
discarded. Finally we got 121 sequences: 27 with ‘‘No
signiﬁcant similarity found’’, and 94 with one or more hits
but without a BLAST mycobacterial hit.
Nineteen sequences were discarded because already
analysed in other publications (Bannantine et al., 2002,
2004b).
To continue this selection, the programs Psort II and
TMHMM were used to ﬁnd the subcellular localisation of
the protein. Proteins predicted to have more than three
transmembrane helices were also discarded.
Finally, 87 putative proteins speciﬁc for Map were
identiﬁed by this in silicomethod (Table SII): 25 sequences
belonged to the annotated proteins of Map; 22 sequences
had a BLAST with a result: ‘‘No signiﬁcant similarity
found’’; and 40 putative proteins had a positive BLASTp but
without a hit for other mycobacteria.
The antigenicity-driven selection based on three online
available T cell epitope prediction programs (Tsites, BIMAS
and SYFPEITHI) permitted ﬁnally to select three sequences
as the putatively most potent to be analysed for
antigenicity in an antibody ELISA test (Table 1). Sequence
of Antigen 7 (coordinates: 1791069–1792508) corre-
sponds to MAP1637c. Sequence of antigen 6 (coordinates:
complement 886138–886530) has not been annotated in
itself but it overlaps two sequences annotated on the
complementary strand, MAP0864 (coordinates: 886023–
886448) and MAP0865 (coordinates: 886451–887722).
Sequence of antigen 5 (2383504–2384184) has not been
annotated.
3.2. Production of candidate antigens
The three antigens were successfully cloned into the
pQE-80L expression vector (QIAGEN), and expressed in E.
coli as histidine-tagged proteins (data not shown). For an
unknown reason, overnight expressionwas not suitable for
Ag6 and was replaced by a 4 h induction It is possible that
Ag6 presents some toxicity that would impair its overnight
expression. All three antigens were expressed as inclusion
bodies and required urea extraction. Moreover, Ag5 was
only partially extracted in urea and use of detergent was
necessary to obtain satisfactory yields.
3.3. Puriﬁcation of candidate antigens
First, puriﬁed candidate antigens were analysed by
mass spectrometry to conﬁrm that the produced proteins
matched the selected speciﬁc nucleotide sequences. For
antigens 5 and 6, peptide mass ﬁngerprints of tryptic
digests corresponded to the right sequences. For antigen 7,
on the other hand, in addition to a faster than expected
Table 1
Coordinates of the three selected sequences on Map chromosome.
NCBI reference Protein name Location pCDS on NC_002944.2
Antigen 7 NP_960571.1 MAP1637c Complement 1791402–1792508
Antigen 6 N.D. N.D. Complement 886138–886530
Antigen 5 N.D. N.D. Complement 2383504–2384184
Fig. 1. SDS-PAGE analysis of puriﬁed candidate antigens. Puriﬁcation efﬁciency was very high thanks to the use of an imidazole gradient for elution instead
of the generally used step procedure. Contamination was monitored by mass spectrometry of all visible bands in the sample. Except for two unidentiﬁed
bands in Ag7 (#), all other protein bands belonged to the studied proteins and resulted from degradation/polymerisation phenomena.
Fig. 2. Comparison of results obtained using Pourquier and Ag5-, Ag6- and
Ag7-based ELISA. For Ag5, no signiﬁcant difference was found between
signals obtained with control, and MAP+ sera (Se: 27.8%; Sp: 97.92%). On
the other hand, sensitivities of 72.2% (46.52–90.31%, 95% CI) and 77.8%
(52.36–93.59%, 95% CI) were obtained in four independent experiments
realised with Ag6 and Ag7, respectively, with a constant speciﬁcity of
97.9% for both. These results clearly suggest that Ag6 and Ag7 could be
valuable tools for development of an ELISA-based diagnostic test of Map
infection in cattle.
B. Leroy et al. / Veterinary Microbiology 135 (2009) 313–319316migration in SDS-PAGE, no peptides were identiﬁed in the
N-terminal region of the puriﬁed protein. Sequencing of
the cloned insert reveals the loss of this particular region.
Only corrected coordinates are presented in Table 1.
IMAC strategy using an imidazole gradient rather than
the common step procedure was particularly efﬁcient for
antigen puriﬁcation. Indeed, puriﬁed and concentrated
antigens were analysed by SDS-PAGE and all Coomassie
stained bands were analysed by mass spectrometry
(Fig. 1). In this analysis, all proteins bands were identiﬁed
as belonging to the candidate antigens studied and
resulting from polymerisation/degradation phenomena.
Two weak protein bands in Ag7 sample (indicated by # in
Fig. 1) were not derived from this antigen and were no E.
coli contaminants either. Puriﬁcation yields were in the
range of 0.3–0.6 mg of candidate antigens/g of bacteria.
3.4. Serological assay
The three candidate antigens were tested individually
for their ability to discriminate Map infected animals from
the negative controls originating from two M. bovis
infected herds. Most of the negative controls had their
M. bovis-sensitised status conﬁrmed by the ESAT6- and
CFP10-based interferon gamma test or by post-mortemM.
bovis isolation. Two different coating conditions were
tested as well as two different secondary antibodies.
Whatever the plate coating conditions, Ag5 gave the worst
results. Indeed the discrimination that could be madebetween the responses obtained with sera from Map
infected animals and from the negative controls was very
poor [Se: 27.8% (9.70–53.48%, 95% CI); Sp: 97.92% (88.93–
99.95%, 95% CI)]. Clearly, this antigen has no potential as
diagnostic antigen since it failed in discriminating Map
infected cattle (Fig. 2).
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formaldehyde were only slightly better, resulting in
sensitivities of 44.4% (21.5–67.4%, 95% CI) and 66.7%
(44.9–88.4%, 95% CI), respectively, at a given speciﬁcity of
97.9% (93.9–100%, 95% CI) (data not shown). However, in
contrast to what has been observed in previous studies
(Leroy et al., 2007; Speer et al., 2006), sensitivity was
increased by using a carbonate buffer for plate coating.
Indeed, as shown in Fig. 2, sensitivities of 72.2% (46.52–
90.31%, 95% CI) and 77.8% (52.36–93.59%, 95% CI) were
obtained in four independent experiments carried outwith
Ag6 and Ag7, respectively, at a constant speciﬁcity of 97.9%
for both (Fig. 2). For Ag7, the sensitivity could be further
increased by use of an IgG-speciﬁc monoclonal antibody
from Bio-X Diagnostic. Indeed, use of this secondary
antibody permitted to enhance the sensitivity of the test to
83.3% for a speciﬁcity of 97.9% (data not shown). For Ag6,
responses were not systematically increased using this
Mab.
All these results are particularly interesting when
compared to results obtained with the Pourquier test in
a duplicate analysis (Table SI). Pourquier test when used to
probe our panel of sera yielded a sensitivity of 72.2%
(46.52–90.31%, 95% CI) for a speciﬁcity of 91.7 (83.8–99.5%,
95% CI) (Fig. 2). It thus seems that Ag6 and Ag7 performed
better separately than the Pourquier test in discriminating
Map infected cattle from negative controls originating
from M. bovis infected herds. Nevertheless, no statistical
difference between both tests was observed using a
McNemar’s test (data not shown).
4. Discussion
Mycobacterium avium subsp. paratuberculosis (Map) is
the etiologic agent of bovine paratuberculosis, also called
Johne’s disease. As no effective therapeutics presently exist
to combat Johne’s disease, and because current vaccines
interfere with control programs for bovine tuberculosis,
large-scale testing and conﬁnement of infected animal is
the only reasonable way to limit disease prevalence in
cattle (Harris and Barletta, 2001). However, despite several
years of development, currently available diagnostic tests
still lack performance to be used in large-scale control
programs. Among the different available diagnostic tools
(PCR, faecal culture etc.), serodiagnosis is the most
promising. Indeed, ELISA-based serological tests are easy
to perform, cheap to produce and do not require dedicated
facilities. In these current commercial ELISAs, antigens
used for plate coating are different, crude bacterial extracts
requiringM. phlei pre-absorption of sera in order to remove
cross-reactive antibodies. This pre-absorption step is not
only time consuming but also affects test sensitivity
(McKenna et al., 2005; Sockett et al., 1992). This is themain
reason why we have chosen to focus our effort on the
development of a serodiagnostic test based on one or a
handful of puriﬁed antigens rather than on a Map extract.
In this study, a genomic analysis of Map genome
allowed us to identify in silico Map-speciﬁc candidate
antigens. A similar approach has already been used by
other authors using approximately half of the M. avium
subsp. paratuberculosis genome (Bannantine et al., 2002,2004b). On the contrary we used almost all the Map
genome to perform our search and actually nineteen
sequences were found in common with these previous
reports, demonstrating the validity of the chosen selection
criteria. As their serodiagnostic potential has already been
evaluated, these 19 sequences were discarded from our
analysis.
Among the database of 87 Map-speciﬁc sequences,
potentially antigenic proteins were identiﬁed using
bioinformatic tools. These last steps led to the ﬁnal
selection of three Map-speciﬁc candidate antigens, named
Ag5, Ag6 and Ag7.
These three genes were cloned and produced as
recombinant his-tagged proteins in E. coli. Antibody
ELISA-based serological test was used to evaluate their
ability to discriminate Map infected cattle from negative
controls. Ag5 clearly demonstrated insufﬁcient antigeni-
city since no clear increase in the signal obtained with sera
of Map infected animals could be recorded. Results
obtained with the two other antigens were clearly more
encouraging. Indeed, ELISA-based serological test using
Ag6 and Ag7 as coating antigens permitted to reach
sensitivities of 72.2% and 83.3%, respectively. The Pour-
quier test, one of the mostly used tests in Europe, yielded
on the same panel of sera, a sensitivity of 72.2% and a Sp of
91.7%. Clearly, ELISA-based serological tests using Ag6 and
Ag7 are at least as sensitive as Pourquier test used in
standard conditions and should now be evaluated with a
larger panel of sera.
Interestingly, the results obtained with Ag6 and Ag7
were better using coating with carbonate than with
formaldehyde. In a previous report the positive effect of
formaldehyde was clearly demonstrated (Leroy et al.,
2007; Speer et al., 2006) and explained by a better ﬁxation
of the antigen to the microwell plate through the ﬁxative
effect of formaldehyde. However, this explanation is not
supported by the observations with Ag6 and Ag7 reported
here. It is possible that formaldehyde plays a positive role
in antigen detection by stabilisation of some epitopes by
covalent cross-link formation. This cross-linking could be
detrimental for antibodies directed against certain pro-
teins such as Ag6 and Ag7. In this study, Pourquier test has
been used according to the manufactory’s protocols
without evaluation of formaldehyde treatment. A possible
positive effect on sensitivity of the Pourquier test should be
evaluated.
It is interesting to note that the sequence of antigen 6
overlaps the complementary strand of MAP0864 and
MAP0865 but on the reverse strand, protein sequences
thus having no similarities. These two sequences were
also selected based on their speciﬁcity by Bannantine et al.
(2008b). MAP0865 was one of the most immunogenic
antigens in the developed protein array analysis. More-
over, in a very recent publication Bannantine et al. (2008a)
showed that MAP0865 could be detected as early as 70
days post-infection by sera from experimentally infected
animals. Finally, these proteins also gave good results in
an ELISA-based test for the diagnosis of ovine paratu-
berculosis (Bannantine et al., 2008c). It is astonishing that
this particular nucleotide sequence leads to two com-
pletely different proteins both appearing ﬁnally very
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sequence of antigen 6 has been veriﬁed by mass spectro-
metry and its peptidemass ﬁngerprint corresponds to the
sequence deduced from the nucleotide sequence. Such a
precautionwas also taken in study involvingMAP0865 by
sequencing the cloned insert.
The control sera used in this analysis were all from
animals from two M. bovis infected herds with no known
cases of Map infection. Most of the animals were positive
in an ESAT6- and CFP10-based interferon gamma test,
conﬁrming the within-herd sensitisation to M. bovis
(Aagaard et al., 2006), further demonstrated by its
isolation in half of the cattle. This group of negative
control cattle thus represents very stringent discriminat-
ing conditions. Facing these negative controls, speciﬁcity
of the Map Pourquier test was only of 91.6%, i.e. four sera
among 48 were detected as false-positive. Speciﬁcity
obtained with Ag6 and Ag7 as coating antigens was 97.9%
for both. It means that the strategy chosen here, i.e. in
silico genomic analysis for selection of Map-speciﬁc genes
has been efﬁcient. Our results also suggest that when
tested with M. bovis sensitised animals, the speciﬁcity of
the Pourquier test decreases signiﬁcantly in comparison
to what is generally observed (>99%; Christopher-
Hennings et al., 2003). It is possible that M. bovis cross
reactivity is not completely abolished by pre-absorption
on M. phlei extract. The actual speciﬁcity of pre-absorbed
tests is generally not calculated using M. bovis sensitised
animals.
Obviously, the use of a ‘golden’ antigen should be able
to discriminate all infected animals regardless of their
clinical stage and with a very small false-positive rate. But
it is now clear that such an antigen probably does not exist
and that the most efﬁcient diagnostic test would be based
on a combination of puriﬁed antigens. Moreover, Bannan-
tine and coworkers (2008a) have demonstrated, using an
experimental infection model, that diagnostic efﬁciency of
an antigen could vary and decrease over the course of the
infection. Thus antigens effective in detection of clinical
cases could be inefﬁcient for early diagnosis. In this
context, antigens presenting sensitivities of more than 70%
in an individual test, such as Ag6 and Ag7, must be
regarded as good candidates to formulate an antigen
combination useful to develop a high efﬁciency ELISA-
based serological test.
Finally, the results obtained in this study clearly
indicate that a genomic analysis in search for speciﬁcity,
combined with a bioinformatic analysis in search of
potential immunogenicity is efﬁcient to select candidate
antigens. This approach is undoubtedly complementary
to the immunoproteomic analysis we have already
performed in the same context. Indeed, if the immuno-
proteomic approach has been shown to be very efﬁcient,
not all proteins expressed in vivo by Map are sampled in
this analysis and thus some very potent antigens might
be missed. These antigens could be detected by the
genomic in silico analysis. On the other hand, immuno-
proteomic analysis has also shown us that some
proteins, even if they are not completely Map speciﬁc,
could lead to sufﬁcient speciﬁcity to be included in a
diagnostic test.Acknowledgement
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